Entero Healthcare to announce Q2 and half-year results on November 12

Entero Healthcare Solutions Limited announced its board of directors will convene on Wednesday, November 12, 2025. The meeting's primary agenda includes the consideration, approval, and record-taking of the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025.

In preparation for this announcement, the trading window for all designated persons and their immediate relatives has been closed since October 1, 2025. This restriction will remain in effect until 48 hours after the financial results are uploaded to the stock exchange portal. The announcement follows Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The communication, dated October 29, 2025, was addressed to the head of listing compliance departments at both BSE Limited and the National Stock Exchange of India Limited.